BATS BZX Real-Time Price
As of 12:04pm ET
| -0.18 / -2.27%|
The 6 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 7.50, with a high estimate of 16.00 and a low estimate of 7.00. The median estimate represents a -3.23% decrease from the last price of 7.75.
The current consensus among 7 polled investment analysts is to Hold stock in Achillion Pharmaceuticals Inc. This rating has held steady since April, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.